Berrey M Michelle 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jun 15, 2021
Insider Transaction Report
Form 4
Berrey M Michelle
President, R&D and CMO
Transactions
- Award
Common Stock
2021-06-14+67,118→ 67,118 total - Award
Option to Purchase Common Stock
2021-06-14+93,000→ 93,000 totalExercise: $21.38Exp: 2031-06-14→ Common Stock (93,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the shares subject to the award will vest on the first anniversary of the Vesting Commencement Date, and the remaining shares will vest in equal quarterly installments in arrears over the three-year period commencing on the first anniversary of the Vesting Commencement Date and ending on the fourth anniversary of the Vesting Commencement Date. The Vesting Commencement Date is June 14, 2021.
- [F2]1/4th of the options subject to the award will vest and become exercisable on the first anniversary of the Vesting Commencement Date, and the remaining options will vest and become exercisable in equal monthly installments in arrears over the three-year period commencing on the first anniversary of the Vesting Commencement Date and ending on the fourth anniversary of the Vesting Commencement Date. The Vesting Commencement Date is June 14, 2021.